UniProt ID | COR1A_HUMAN | |
---|---|---|
UniProt AC | P31146 | |
Protein Name | Coronin-1A | |
Gene Name | CORO1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 461 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Cytoplasm, cell cortex. Cytoplasmic vesicle, phagosome membrane. In non-infected macrophages, associated with the cortical microtubule network. In mycobacteria-infected macrophages, becomes progressively relocalized and retai | |
Protein Description | May be a crucial component of the cytoskeleton of highly motile cells, functioning both in the invagination of large pieces of plasma membrane, as well as in forming protrusions of the plasma membrane involved in cell locomotion. In mycobacteria-infected cells, its retention on the phagosomal membrane prevents fusion between phagosomes and lysosomes.. | |
Protein Sequence | MSRQVVRSSKFRHVFGQPAKADQCYEDVRVSQTTWDSGFCAVNPKFVALICEASGGGAFLVLPLGKTGRVDKNAPTVCGHTAPVLDIAWCPHNDNVIASGSEDCTVMVWEIPDGGLMLPLREPVVTLEGHTKRVGIVAWHTTAQNVLLSAGCDNVIMVWDVGTGAAMLTLGPEVHPDTIYSVDWSRDGGLICTSCRDKRVRIIEPRKGTVVAEKDRPHEGTRPVRAVFVSEGKILTTGFSRMSERQVALWDTKHLEEPLSLQELDTSSGVLLPFFDPDTNIVYLCGKGDSSIRYFEITSEAPFLHYLSMFSSKESQRGMGYMPKRGLEVNKCEIARFYKLHERRCEPIAMTVPRKSDLFQEDLYPPTAGPDPALTAEEWLGGRDAGPLLISLKDGYVPPKSRELRVNRGLDTGRRRAAPEASGTPSSDAVSRLEEEMRKLQATVQELQKRLDRLEETVQAK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRQVVRSS ------CCCHHHHHH | 31.27 | 23100250 | |
2 | Acetylation | ------MSRQVVRSS ------CCCHHHHHH | 31.27 | 23100250 | |
8 | Phosphorylation | MSRQVVRSSKFRHVF CCCHHHHHHHHHHHH | 26.69 | 24719451 | |
9 | Phosphorylation | SRQVVRSSKFRHVFG CCHHHHHHHHHHHHC | 25.83 | 21406692 | |
20 | Acetylation | HVFGQPAKADQCYED HHHCCCCCCCHHCCC | 60.21 | 23749302 | |
20 | Ubiquitination | HVFGQPAKADQCYED HHHCCCCCCCHHCCC | 60.21 | 21890473 | |
25 | Phosphorylation | PAKADQCYEDVRVSQ CCCCCHHCCCCCCCC | 14.99 | 27155012 | |
33 | Phosphorylation | EDVRVSQTTWDSGFC CCCCCCCCCCCCCEE | 23.50 | - | |
34 | Phosphorylation | DVRVSQTTWDSGFCA CCCCCCCCCCCCEEE | 21.45 | - | |
54 | Phosphorylation | VALICEASGGGAFLV EEEEEECCCCCEEEE | 18.71 | 30301811 | |
66 | Ubiquitination | FLVLPLGKTGRVDKN EEEEECCCCCCCCCC | 56.33 | - | |
132 | Acetylation | VTLEGHTKRVGIVAW EEEECCCCEEEEEEE | 39.14 | 25953088 | |
178 | Phosphorylation | GPEVHPDTIYSVDWS CCCCCCCCEEEEEEC | 26.68 | - | |
180 | Phosphorylation | EVHPDTIYSVDWSRD CCCCCCEEEEEECCC | 12.53 | - | |
181 | Phosphorylation | VHPDTIYSVDWSRDG CCCCCEEEEEECCCC | 15.11 | - | |
193 | Phosphorylation | RDGGLICTSCRDKRV CCCCEEEECCCCCCE | 24.70 | 28450419 | |
194 | Phosphorylation | DGGLICTSCRDKRVR CCCEEEECCCCCCEE | 11.62 | 28450419 | |
207 | Ubiquitination | VRIIEPRKGTVVAEK EEEECCCCCEEEEEC | 70.42 | - | |
214 | Ubiquitination | KGTVVAEKDRPHEGT CCEEEEECCCCCCCC | 49.66 | - | |
230 | Phosphorylation | PVRAVFVSEGKILTT CEEEEEEECCCEEEE | 29.21 | 28348404 | |
233 | Acetylation | AVFVSEGKILTTGFS EEEEECCCEEEECCC | 30.41 | 23749302 | |
233 | Ubiquitination | AVFVSEGKILTTGFS EEEEECCCEEEECCC | 30.41 | 21890473 | |
236 | Phosphorylation | VSEGKILTTGFSRMS EECCCEEEECCCCCC | 28.48 | 21406692 | |
237 | Phosphorylation | SEGKILTTGFSRMSE ECCCEEEECCCCCCC | 32.55 | 21406692 | |
240 | Phosphorylation | KILTTGFSRMSERQV CEEEECCCCCCCCCE | 28.55 | 21406692 | |
253 | Ubiquitination | QVALWDTKHLEEPLS CEEEECCCCCCCCCC | 43.66 | - | |
268 | Phosphorylation | LQELDTSSGVLLPFF HHEECCCCCCEEEEE | 34.71 | 28464451 | |
290 | O-linked_Glycosylation | YLCGKGDSSIRYFEI EEECCCCCEEEEEEE | 36.01 | 29351928 | |
291 | O-linked_Glycosylation | LCGKGDSSIRYFEIT EECCCCCEEEEEEEC | 18.80 | 29351928 | |
294 | Phosphorylation | KGDSSIRYFEITSEA CCCCEEEEEEECCCC | 12.14 | 30576142 | |
299 | Phosphorylation | IRYFEITSEAPFLHY EEEEEECCCCCHHHH | 37.11 | - | |
306 | Phosphorylation | SEAPFLHYLSMFSSK CCCCHHHHHHHHCCC | 11.56 | 30576142 | |
311 | Phosphorylation | LHYLSMFSSKESQRG HHHHHHHCCCCHHCC | 31.68 | 30576142 | |
313 | Ubiquitination | YLSMFSSKESQRGMG HHHHHCCCCHHCCCC | 61.25 | 21890473 | |
313 | Acetylation | YLSMFSSKESQRGMG HHHHHCCCCHHCCCC | 61.25 | 156829 | |
324 | Ubiquitination | RGMGYMPKRGLEVNK CCCCCCCCCCCCCCH | 42.44 | - | |
331 | Acetylation | KRGLEVNKCEIARFY CCCCCCCHHHHHHHH | 38.12 | 23749302 | |
331 | Ubiquitination | KRGLEVNKCEIARFY CCCCCCCHHHHHHHH | 38.12 | - | |
339 | Ubiquitination | CEIARFYKLHERRCE HHHHHHHHHHHCCCE | 40.43 | 19608861 | |
339 | Acetylation | CEIARFYKLHERRCE HHHHHHHHHHHCCCE | 40.43 | 19608861 | |
350 | Sulfoxidation | RRCEPIAMTVPRKSD CCCEECEEECCCHHH | 3.93 | 21406390 | |
355 | Ubiquitination | IAMTVPRKSDLFQED CEEECCCHHHCCCCC | 42.10 | - | |
356 | Phosphorylation | AMTVPRKSDLFQEDL EEECCCHHHCCCCCC | 40.60 | 22817900 | |
364 | Phosphorylation | DLFQEDLYPPTAGPD HCCCCCCCCCCCCCC | 21.35 | 27642862 | |
367 | Phosphorylation | QEDLYPPTAGPDPAL CCCCCCCCCCCCCCC | 39.48 | 28122231 | |
391 | Phosphorylation | DAGPLLISLKDGYVP CCCCEEEEECCCCCC | 29.36 | 27067055 | |
393 | Ubiquitination | GPLLISLKDGYVPPK CCEEEEECCCCCCCC | 42.17 | - | |
396 | Phosphorylation | LISLKDGYVPPKSRE EEEECCCCCCCCCCC | 21.66 | 27642862 | |
400 | Ubiquitination | KDGYVPPKSRELRVN CCCCCCCCCCCCCCC | 56.95 | - | |
412 | Phosphorylation | RVNRGLDTGRRRAAP CCCCCCCCCCCCCCC | 37.32 | 26074081 | |
422 | Phosphorylation | RRAAPEASGTPSSDA CCCCCCCCCCCCHHH | 41.35 | 28387310 | |
424 | Phosphorylation | AAPEASGTPSSDAVS CCCCCCCCCCHHHHH | 19.94 | 23401153 | |
424 | O-linked_Glycosylation | AAPEASGTPSSDAVS CCCCCCCCCCHHHHH | 19.94 | OGP | |
426 | Phosphorylation | PEASGTPSSDAVSRL CCCCCCCCHHHHHHH | 40.46 | 29255136 | |
427 | Phosphorylation | EASGTPSSDAVSRLE CCCCCCCHHHHHHHH | 30.69 | 29255136 | |
431 | Phosphorylation | TPSSDAVSRLEEEMR CCCHHHHHHHHHHHH | 32.63 | 29255136 | |
439 | Acetylation | RLEEEMRKLQATVQE HHHHHHHHHHHHHHH | 43.57 | 25953088 | |
439 | Ubiquitination | RLEEEMRKLQATVQE HHHHHHHHHHHHHHH | 43.57 | - | |
449 | Acetylation | ATVQELQKRLDRLEE HHHHHHHHHHHHHHH | 68.50 | 19608861 | |
449 | Ubiquitination | ATVQELQKRLDRLEE HHHHHHHHHHHHHHH | 68.50 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
412 | T | Phosphorylation |
| 23100250 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COR1A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615401 | Immunodeficiency 8 (IMD8) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-449, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASSSPECTROMETRY. |